2011
DOI: 10.1371/journal.pone.0021099
|View full text |Cite
|
Sign up to set email alerts
|

Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors

Abstract: This study aims to examine whether or not cancer stem cells exist in malignant peripheral nerve sheath tumors (MPNST). Cells of established lines, primary cultures and freshly dissected tumors were cultured in serum free conditions supplemented with epidermal and fibroblast growth factors. From one established human MPNST cell line, S462, cells meeting the criteria for cancer stem cells were isolated. Clonal spheres were obtained, which could be passaged multiple times. Enrichment of stem cell-like cells in th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
44
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(47 citation statements)
references
References 17 publications
2
44
1
Order By: Relevance
“…With regards to CSCs conflicting reports abound. Downregulation of NCAM in CSC populations is observed in peripheral neural sheath tumors 114 in contrast to reports in GBM where NCAM expression correlates with Olig 2 expression, a well-known GBM stem cell marker. 113 Additional studies are required to further address these issues, better define the role of NCAM in microenvironmental regulation and clarify the expression of NCAM in CSCs and other tumor microenvironment cells.…”
Section: Ncamcontrasting
confidence: 68%
“…With regards to CSCs conflicting reports abound. Downregulation of NCAM in CSC populations is observed in peripheral neural sheath tumors 114 in contrast to reports in GBM where NCAM expression correlates with Olig 2 expression, a well-known GBM stem cell marker. 113 Additional studies are required to further address these issues, better define the role of NCAM in microenvironmental regulation and clarify the expression of NCAM in CSCs and other tumor microenvironment cells.…”
Section: Ncamcontrasting
confidence: 68%
“…These results suggest that the tumors originated from neural crest cells, such as Schwann cells or striated muscle cells, and some contained possible cancer stem cells because nestin, NGFR, and CD133 are stem cell markers. 2,3,14,17 The ability of neural crest cells to differentiate into a diverse range of cell types explains the expression of Schwannian and striated muscle markers in the neoplastic cells. The cytoplasmic granules in the neoplastic cells were positive for LC3, p62, NBR1, and ubiquitin.…”
Section: Discussionmentioning
confidence: 99%
“…Further studies of both CTVT and DFTD from a CSC perspective may also provide insight to their respective analogous human cancers (as currently understood), where the CSC model has been investigated. Some data, while equivocal and subject of some discussion, suggest that certain neural crest cancers (e.g., melanoma, neuroblastoma) may have a CSC component [33,[52][53][54], and recent data indicates that putative CSCs may exist in certain MPNST cell lines [55]. The neural crest origin for DFTD implies that a similar evaluation for CSCs may be of interest to biologists investigating such cancers.…”
Section: Discussion and Possible Utility Of A Csc Approachmentioning
confidence: 99%